S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
OTCMKTS:IGNE

Igene Biotechnology Stock Forecast, Price & News

$0.0001
0.00 (0.00%)
(As of 11/1/2021)
Add
Compare
Today's Range
$0.00
$0.00
50-Day Range
N/A
52-Week Range
$0.00
$0.00
Volume
31,100 shs
Average Volume
2.57 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.35
30 days | 90 days | 365 days | Advanced Chart
Receive IGNE News and Ratings via Email

Sign-up to receive the latest news and ratings for Igene Biotechnology and its competitors with MarketBeat's FREE daily newsletter.


About Igene Biotechnology

IGENE Biotechnology, Inc. engages in the research, development, production, and commercialization of specialty ingredients for human and animal nutrition. It offers feed ingredients and nutraceutical products that includes astaxanthin. The company was founded by Robert Austin Milch and William T. Hall on October 27, 1981 and is headquartered in Columbia, MD.

Headlines

Igene Biotechnology, Inc. (IGNE)
October 8, 2021 |  ca.finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry
Agricultural chemicals
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:IGNE
CIK
N/A
Employees
18
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Optionable
Not Optionable

Company Calendar

Today
12/06/2021
Fiscal Year End
12/31/2021

MarketRank

Overall MarketRank

0.33 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












Igene Biotechnology (OTCMKTS:IGNE) Frequently Asked Questions

Who are Igene Biotechnology's key executives?

Igene Biotechnology's management team includes the following people:
  • Stephen F. Hiu, President, Director & Chief Technology Officer

What is Igene Biotechnology's stock symbol?

Igene Biotechnology trades on the OTCMKTS under the ticker symbol "IGNE."

How do I buy shares of Igene Biotechnology?

Shares of IGNE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Igene Biotechnology's stock price today?

One share of IGNE stock can currently be purchased for approximately $0.00.

How many employees does Igene Biotechnology have?

Igene Biotechnology employs 18 workers across the globe.

What is Igene Biotechnology's official website?

The official website for Igene Biotechnology is www.igene.com.

Where are Igene Biotechnology's headquarters?

Igene Biotechnology is headquartered at 9110 RED BRANCH RD SUITE J, COLUMBIA MD, 21045-2024.

How can I contact Igene Biotechnology?

Igene Biotechnology's mailing address is 9110 RED BRANCH RD SUITE J, COLUMBIA MD, 21045-2024. The company can be reached via phone at (410) 997-2599 or via fax at 410-997-1392.


This page was last updated on 12/6/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.